Effects of Exercise Intervention on Muscle Strength in Severely Ill Patients

April 18, 2022 updated by: Taipei Veterans General Hospital, Taiwan

In recent years, due to the improvement in the survival rate of the intensive care unit, the problem of severe systemic fatigue (Intensive care unit acquired weakness; ICUAW) has continued to receive attention. Muscle mass decreases by 3-11% within a week, resulting in decreased muscle strength and muscle atrophy. Current studies suggest that ICUAW can lead to poorer function, prolonged ICU stay, and decreased quality of life.

This study aimed to understand the muscle strength of critically ill patients and to explore the effect of exercise intervention on improving muscle strength. The experimental group received a four-week exercise bike intervention plus conventional rehabilitation exercises, while the control group received conventional rehabilitation exercises.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The content of the exercise is to use an exercise bike, start pedaling on the first day, time setting: 20 minutes, speed: 2, and adopt passive mode. If you can complete the exercise on the first day, the time will be adjusted to 30 minutes on the second day. If you cannot complete the exercise on the first day, the time will still start from 20 minutes on the second day. The maximum time is 30 minutes. If you can complete 30 minutes of passive exercise for 3 consecutive days, the fourth day will be adjusted to active exercise. The entire exercise training is seven days a week, once a day, once a 30-minute, at least 5 days. Those who were discharged to the general ward continued to complete this exercise training for up to 28 days. Stop exercising if heartbeat > 140, mean arterial pressure < 65, blood oxygen < 90%, respiration > 35 beats/min, or the patient requests to stop during exercise.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taipei City, Taiwan
      • Taipei, Taipei City, Taiwan, Taiwan
        • TaipeiVGH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Aged over 20 years old
  2. Conscious
  3. willing to participate in this study, and signed the consent form
  4. no lower extremity activity taboo, and can walk independently before admission

Exclusion Criteria:

  1. Have neuromuscular disease.
  2. Unable to step on a bed bike.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: exercise bike
exercise is to use an exercise bike, start pedaling on the first day, time setting: 20 minutes, speed: 2, and adopt passive mode. If you can complete the exercise on the first day, the time will be adjusted to 30 minutes on the second day. If you cannot complete the exercise on the first day, the time will still start from 20 minutes on the second day. The maximum time is 30 minutes. If you can complete 30 minutes of passive exercise for 3 consecutive days, the fourth day will be adjusted to active exercise. The entire exercise training is seven days a week, once a day, once a 30-minute, at least 5 days. Those who were discharged to the general ward continued to complete this exercise training for up to 28 days.
exercise is to use an exercise bike, start pedaling on the first day, time setting: 20 minutes, speed: 2, and adopt passive mode. If you can complete the exercise on the first day, the time will be adjusted to 30 minutes on the second day. If you cannot complete the exercise on the first day, the time will still start from 20 minutes on the second day. The maximum time is 30 minutes. If you can complete 30 minutes of passive exercise for 3 consecutive days, the fourth day will be adjusted to active exercise. The entire exercise training is seven days a week, once a day, once a 30-minute, at least 5 days. Those who were discharged to the general ward continued to complete this exercise training for up to 28 days.
NO_INTERVENTION: regular rehabilitation exercises
walking exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Basic Demographic Health Assessment Form
Time Frame: baseline
Age, sex, diagnosis, disease severity, reason for ICU admission
baseline
days in intensive care unit
Time Frame: baseline
Health Assessment Form
baseline
days on ventilator
Time Frame: baseline
Health Assessment Form
baseline
total days in hospital
Time Frame: baseline
Health Assessment Form
baseline
body mass index
Time Frame: baseline
Health Assessment Form
baseline
level of albumin
Time Frame: baseline
Health Assessment Form
baseline
The daily observation record sheet includes
Time Frame: up to 28 days
Vital signs,respirator is used or not,bicycle use pattern,speed and time,reasons for stopping
up to 28 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip strength
Time Frame: baseline(T0)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
baseline(T0)
Hand grip strength
Time Frame: 3 days after intervention(T1)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
3 days after intervention(T1)
Hand grip strength
Time Frame: 7 days after intervention(T2)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
7 days after intervention(T2)
Hand grip strength
Time Frame: 10 days after intervention(T3)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
10 days after intervention(T3)
Hand grip strength
Time Frame: 14 days after intervention(T4)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
14 days after intervention(T4)
Hand grip strength
Time Frame: 17 days after intervention(T5)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
17 days after intervention(T5)
Hand grip strength
Time Frame: 21 days after intervention(T6)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
21 days after intervention(T6)
Hand grip strength
Time Frame: 28 days after intervention(T7)
Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength
28 days after intervention(T7)
foot lift
Time Frame: baseline(T0)
Use a tape to measure foot lift
baseline(T0)
foot lift
Time Frame: 3 days after intervention(T1)
Use a tape to measure foot lift
3 days after intervention(T1)
foot lift
Time Frame: 7days after intervention(T2)
Use a tape to measure foot lift
7days after intervention(T2)
foot lift
Time Frame: 10days after intervention(T3)
Use a tape to measure foot lift
10days after intervention(T3)
foot lift
Time Frame: 14days after intervention(T4)
Use a tape to measure foot lift
14days after intervention(T4)
foot lift
Time Frame: 17ays after intervention(T5)
Use a tape to measure foot lift
17ays after intervention(T5)
foot lift
Time Frame: 21days after intervention(T6)
Use a tape to measure foot lift
21days after intervention(T6)
foot lift
Time Frame: 28days after intervention(T7)
Use a tape to measure foot lift
28days after intervention(T7)
walking distance in 6 minutes
Time Frame: baseline(T0)
Measure 6-minute walking distance
baseline(T0)
walking distance in 6 minutes
Time Frame: 3 days after intervention(T1)
Measure 6-minute walking distance
3 days after intervention(T1)
walking distance in 6 minutes
Time Frame: 7 days after intervention(T2)
Measure 6-minute walking distance
7 days after intervention(T2)
walking distance in 6 minutes
Time Frame: 10days after intervention(T3)
Measure 6-minute walking distance
10days after intervention(T3)
walking distance in 6 minutes
Time Frame: 14days after intervention(T4)
Measure 6-minute walking distance
14days after intervention(T4)
walking distance in 6 minutes
Time Frame: 17days after intervention(T5)
Measure 6-minute walking distance
17days after intervention(T5)
walking distance in 6 minutes
Time Frame: 21days after intervention(T6)
Measure 6-minute walking distance
21days after intervention(T6)
walking distance in 6 minutes
Time Frame: 28ays after intervention(T7)
Measure 6-minute walking distance
28ays after intervention(T7)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tao-Fen Hsiung, Taipei Veterans General Hospital, Taiwan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 17, 2020

Primary Completion (ACTUAL)

March 1, 2022

Study Completion (ACTUAL)

March 1, 2022

Study Registration Dates

First Submitted

March 2, 2022

First Submitted That Met QC Criteria

April 18, 2022

First Posted (ACTUAL)

April 22, 2022

Study Record Updates

Last Update Posted (ACTUAL)

April 22, 2022

Last Update Submitted That Met QC Criteria

April 18, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-07-022B

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intensive Care Unit Patients

Clinical Trials on exercise bike

Subscribe